The rooftops came first; the medicine is catching up
Anyone who has watched south Hillsborough fill in over the last decade understands what growth outpacing infrastructure feels like. New subdivisions keep opening while the clinical side of the map fills in more slowly, so for anything past urgent care, Riverview patients have long been used to looking north for their specialists.
Cannabis certification inverted that pattern. It arrived early and abundantly, because a certification storefront needs almost nothing to open: a lease, a registered physician's signature, and a card reader. What that business model cannot carry is the actual medicine around the decision. Whether your pain generator has been imaged. Whether the sleep problem being medicated is untreated PTSD. Whether cannabis will collide with the five other prescriptions on your list. A town can have plenty of places to get certified and still have almost nowhere the certification is treated as a clinical judgment. That gap, more than distance, is what this page is about.
To be clear about our own incentives: Ascend gains nothing from talking anyone out of a certification, and nothing extra from talking anyone into one. The evaluation fee is the same either way, and the recommendation follows the documentation. What we're selling is the judgment, and judgment sometimes says yes, sometimes says not yet, and sometimes says this isn't your answer.
Before the card: is this the right question?
Our program lives inside a family medicine practice, and the evaluation behaves accordingly. You'll spend 30 to 45 minutes with Dr. Saylor, who brings 17 years of clinical experience and serves as Ascend's Chief Medical Officer. He goes through your history, your current medications, and the records documenting the condition you believe qualifies, then gives you a straight accounting of what research supports cannabis for that condition, what the side effects and interactions look like, and how the state card process unfolds from the visit forward. Alternatives get discussed in the same breath, sometimes alongside cannabis and sometimes instead of it, because a recommendation that ignores every other option isn't a recommendation, it's an upsell.
Bring documentation: specialist notes, imaging, prior treatment trials, anything that establishes the diagnosis on paper. Florida's structure runs on records, and strong ones can let the registry entry happen during the same visit. Weak ones get you honesty instead. If the documentation doesn't support certification, we'll tell you what's missing and how to close the gap, whether through our own psychiatric team, a proper pain workup, or care that doesn't involve cannabis at all. No honest clinic can guarantee approval or benefit, and we'd rather be the clinic that says so out loud.
The evaluation also doesn't end when the visit does. Cannabinoids can change how the rest of your care behaves, so when a certification affects medication management for another condition, we communicate with the clinicians handling that condition. A specialist adjusting your regimen deserves to know what else is on board, and keeping them informed is part of the follow-up structure here, not an extra you have to request.
Florida's rulebook in plain English
The program's mechanics come from Section 381.986 of the Florida Statutes and the Department of Health's Office of Medical Marijuana Use (OMMU). A physician must hold qualifying-physician registration with the OMMU to evaluate patients at all. The initial evaluation must be conducted in person; current Florida law offers no fully remote route to a first certification, so an ad promising an entirely online card for a new patient is promising around the statute. If the physician certifies you, the recommendation goes into the Compassionate Use Registry. It's a recommendation rather than a prescription, because cannabis remains Schedule I under federal law and cannot legally be prescribed by anyone.
From there the paperwork becomes yours: you apply to the OMMU for the patient ID card and pay the state's application fee directly to the state, with processing typically taking a few weeks. The card unlocks purchasing at any licensed Medical Marijuana Treatment Center in Florida. Recommendations also expire on a clock. The state's current re-evaluation interval is 210 days, and those renewal visits, unlike the first one, can often be completed by telehealth while you're physically in Florida. In practice, Riverview patients usually attend one in-person evaluation and handle the rest by video.
A word on what those video renewals require, since "telehealth" scares off some patients who shouldn't be scared. You need a camera-equipped phone, tablet, or computer, a connection stable enough for a conversation, and a spot in Florida to take the call. Nothing else. The renewal itself is a real appointment, not a rubber stamp, but it's a real appointment you can take from your living room off Boyette Road instead of a waiting room across the county.
Which conditions qualify, and what the documentation must show
Florida's list, as of this writing: cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class as those listed, terminal conditions diagnosed by a physician other than the certifying one, and chronic nonmalignant pain caused by or originating from a qualifying condition. The legislature can amend that list, so the version that governs your visit is the one in force that day, not the one on any website.
The two most commonly misunderstood entries are also the two most commonly advertised. Chronic pain qualifies only through its connection to a listed condition; the statute asks where the pain originates, and "it hurts and nothing helps" doesn't answer that question without records behind it. PTSD qualifies only as a documented diagnosis, which typically means a formal psychiatric or psychological evaluation somewhere in your chart. Missing that piece isn't a dead end. Ascend runs a psychiatric program, and getting a real diagnostic evaluation first serves you regardless of what happens with cannabis. The other entries, from epilepsy to Crohn's, lean on specialist documentation, so the neurologist's or gastroenterologist's notes are worth the effort to obtain.
Qualifying is also not the same as being managed. For patients who certify, the specialty relationships keep doing the heavy lifting: oncology continues to own cancer care while cannabis addresses nausea or appetite, gastroenterology continues to own Crohn's, neurology continues to own MS spasticity and Parkinson's symptoms, and pain patients keep their non-cannabis treatment plan running rather than swapping it out. Cannabis, where it helps, is a supplement to that structure. It's never a substitute for it, and we'll say so whenever the two get confused.
Reading the evidence without the sales pitch
An honest evidence summary fits in a paragraph, which is itself telling. The National Academies of Sciences reviewed the cannabis literature comprehensively in 2017 and found substantial evidence for benefit in adult chronic pain and chemotherapy-induced nausea and vomiting, moderate evidence for multiple sclerosis spasticity, and limited or insufficient evidence for most other claimed uses, with sparse long-term outcome data throughout. PTSD, the condition behind so much certification volume, sits in genuinely mixed territory. None of this means cannabis can't help a given patient; in many cases it can. It means expectations should be sized to the evidence, and that cannabis generally belongs alongside or after standard care rather than in front of it.
Federal status frames everything else. Cannabis is a Schedule I controlled substance, the FDA has approved it as a treatment for nothing, and the only FDA-approved cannabis-derived prescription drug is a purified CBD formulation for certain rare seizure disorders that has nothing to do with dispensary products. Individual responses vary, interactions and side effects are real, and any clinic promising outcomes has moved from medicine to marketing.
Legal tradeoffs the storefronts skip: impairment, guns, work
A card changes your standing with a dispensary. It does not change your standing at a roadside stop, on a federal firearms form, or under an employer's drug policy, and those three deserve consideration before you apply. Operating a vehicle while impaired by cannabis remains illegal in Florida with or without a card, and the card is no defense in a DUI case. Federal law at 18 U.S.C. § 922(g)(3) makes it unlawful for a controlled-substance user to buy or possess a firearm, and the federal purchase form asks about marijuana use explicitly regardless of state medical status. Employers, meanwhile, are under no Florida obligation to accommodate medical cannabis, so a positive test can still have job consequences, especially in the safety-sensitive and federally contracted freight and logistics work that employs a great many people here.
We walk through each of these at the evaluation because a decision made with the tradeoffs visible holds up better than one discovered at a gun counter or an HR meeting. Evaluations are limited to adults 18 and older. This page is informational and is not legal advice.
What it costs, and who collects each part
Expect self-pay. Because of cannabis's federal Schedule I status, insurance plans almost never cover certification services, whatever Florida permits. Two distinct fees stand between you and a card: our clinical evaluation fee, which the billing team confirms when you call (813) 670-3331, and the OMMU's ID-card application fee, paid directly to the state and entirely separate from anything we charge. When the underlying condition needs ongoing medical management in its own right, that management visit can sometimes be billed to insurance separately from the certification, which is worth asking about on the phone. Renewal visits carry their own clinical fee as well, so ask the billing team to lay out the full cycle up front. Knowing the whole structure before you start beats discovering it 210 days in.
The visit itself happens at 3971 Moran Road, Suite 101, Tampa, FL 33618, in Carrollwood, because nothing in the statute permits an initial certification to be made at a distance. We see patients from across the Riverview ZIP codes, 33569, 33578, and 33579, along with Brandon, Apollo Beach, Ruskin, and Lithia. After your card is issued, any licensed Medical Marijuana Treatment Center in the state will serve you, including the ones closest to home. The part worth choosing carefully was never the dispensary. It's the evaluation that decides whether you should be there at all.
After the visit: the registry, the application, and where the delays live
The appointment is the part patients plan for. The three or four weeks after it are the part almost nobody plans for, and it is where most of the frustration in this program actually happens. Three separate parties are involved, they act in sequence, and none of them can do another's job.
Step one belongs to the physician. If the evaluation supports certification, the recommendation is entered into the Compassionate Use Registry, usually during the same visit. That entry is not a card and it is not permission to buy anything yet. It is a record in a state system saying a qualified physician has made a determination about you.
Step two belongs to you. Once the registry entry exists, you file an application with the Office of Medical Marijuana Use for the state patient identification card and pay the state's fee directly to the department. This step is genuinely yours; no clinic can file it for you, and a patient who assumes the office handled it can sit for weeks waiting on something nobody started. The application asks for proof of Florida residency and a photograph that meets the department's specifications.
Step three belongs to the state. The department reviews the application and issues the card, and current processing typically runs a few weeks rather than a few days. Once issued, the card is what a treatment center asks to see.
The delays cluster in predictable places. A photograph that does not meet specification is the most common single cause of a rejected application, followed by a residency document that has expired or does not match the name on file. Next is the patient who never filed at all. Then there is the address that changed mid-process, which strands the card in the mail. None of these are clinical problems and none of them get faster by calling the physician's office, but knowing they exist is most of the defense against them.
One more thing worth setting straight, because storefront advertising blurs it constantly: nothing about this sequence lets you purchase on the day of your evaluation. A certification produced in fifteen minutes does not shorten the state's part of it by a single day.
The question underneath the question
A lot of people arrive at a certification page having already decided what they want, and the industry is built to agree with them. That is worth noticing, because a business that only ever says yes is not evaluating anything. It is processing.
The more useful question is rarely whether you can obtain a card. For most people with a documented qualifying condition, the answer to that is probably. The question is whether certification is the thing that will actually help, given what is generating your symptoms, what has been tried, and what the evidence supports for your specific condition rather than for cannabis in general.
Sometimes those two questions have the same answer, and certification is a reasonable addition to a plan that has already worked through the alternatives. Sometimes they diverge sharply, and the most valuable outcome of the appointment is finding the thing nobody had looked for. Riverview grew fast enough that a lot of residents here are newly arrived and have never had a full workup in Florida at all, which makes that second outcome more common than you might expect.
What a no actually buys you
A declined certification sounds like a wasted appointment and frequently is not. The reasons a visit ends without a registry entry are diagnostic reasons: the condition is not documented, the pain has never been traced to a source, the psychiatric diagnosis was assumed rather than established. Each of those is a finding, and each points at work worth doing.
That is the practical case for having this conversation inside a family medicine practice rather than at a counter. If the answer is no, there is somewhere for the conversation to go next, and it is the same building. A storefront that declines you has nothing to offer afterward, which is part of why so few of them ever do.
If you are still deciding, start here
- Chronic pain evaluation: the workup that often should come first
- Psychiatry: diagnosis and medication management
- Talk therapy: often the stronger evidence base for psychiatric conditions
- The medical marijuana program: if certification is the right next step
- Apollo Beach certification: further down the South Shore
- Brandon certification: with more on assembling your records
FAQs about medical marijuana evaluation in Riverview
What are Florida's qualifying conditions?
Florida law lists specific qualifying conditions, including cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class, terminal conditions, and chronic nonmalignant pain caused by or originating from a qualifying medical condition. The list can change as state law evolves; we confirm eligibility at your evaluation based on current statute.
Where is the Riverview evaluation done?
The initial Compassionate Use Registry evaluation is done in-person per Florida law at our Tampa-Carrollwood office (3971 Moran Road, Suite 101, Tampa, FL 33618). Ascend has no office in Riverview. Follow-up visits can often be done via telehealth.
Should I try other treatments first?
Usually, and often you already have. Cannabis is not the opening move in a treatment plan, and a certification that skips straight past the standard options for your condition is skipping the part where somebody checks whether a better answer was available. If the standard treatments genuinely have been tried, that history is one of the strongest things you can bring to the appointment.
What non-cannabis options would you consider?
It depends entirely on the condition. For pain that means finding out what is actually generating it, which sometimes has never been properly worked up, and then the range of chronic pain management that follows from the answer. For psychiatric qualifying conditions it means psychiatric evaluation and talk therapy, which for several conditions have a stronger evidence base than cannabis does.
Can I be evaluated if I am already on prescribed pain medication?
Yes, and you should tell us exactly what and how much. Existing prescriptions do not disqualify you, but they change the analysis, particularly with sedatives and controlled substances where the interaction risk is real. Where another physician is prescribing, coordination matters and we will raise it rather than working around it.
What if I am not sure cannabis is right for me?
Then you are approaching it about the way we would want. Uncertainty is a reasonable starting position given how uneven the evidence is by condition, and the evaluation is partly there to resolve it. Some patients arrive undecided and leave certified; others arrive undecided and leave with a plan that does not involve cannabis at all.
Does asking about certification commit me to anything?
No. An evaluation is an appointment, not an enrollment. Nothing is entered in the Compassionate Use Registry unless the clinical answer supports it and you want to proceed, and you can decline at that point for any reason.
What happens to my regular care if I do get certified?
It continues, and ideally it continues with the certification visible inside it. The failure mode we see most often is a card obtained somewhere that never told the patient's own physician, which turns into a problem the first time interactions or surgical planning come up. Certification should be one more documented element of your care rather than a parallel track running beside it.
Sources
- Florida Statute § 381.986 (medical use of marijuana); Florida Department of Health rule Chapter 64-4, F.A.C.
- Florida Office of Medical Marijuana Use (OMMU), patient registry and ID card guidance
- National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids.
- FDA: cannabis-derived drug approvals and cannabis regulatory status
- 18 U.S.C. § 922(g)(3)
Medical cannabis is regulated under Florida Statute §381.986 and is not approved by the FDA for the treatment of any condition. The clinical evidence varies substantially by condition. Side effects and drug interactions exist and are discussed during evaluation. Cannabis remains a federally controlled Schedule I substance. This page is informational and does not substitute for a clinical visit. See Fla. Stat. § 381.986 and the Florida Department of Health, Office of Medical Marijuana Use (Chapter 64-4, F.A.C.).